Kay SeverinKay Severin was born in Germany in 1967. He obtained his Ph.D. in 1995 with a thesis in the group of Prof. W. Beck, University of Munich. Subsequently, he joined the group of Prof. M. R. Ghadiri as a postdoctoral fellow. In 1997, he started independent research projects ("Habilitation") at the Department of Chemistry, University of Munich. In 2001, he became assistant professor at the Institute of Chemical Sciences and Engineering at the Swiss Federal Institute of Technology, Lausanne (EPFL). Since 2009, he is full professor at the same institute.
Awards: Bayerischer Habilitations Förderpreis (1997), ADUC award of the year (2001), Heinz Maier-Leibnitz award of the DFG (2001), award of the Karl-Ziegler foundation (2001), Arnold Sommerfeld award of the Bavarian Academy of Science (2001), Werner Prize of The Swiss Chemical Society (2003), Otto Roelen Medal of the DECHEMA (2005), award for chemistry of the Academy of Sciences, Göttingen (2007), Dalton Transactions European Lectureship (2008).
Gerardo TurcattiSenior scientific level (R&D) with extensive experience in the management of multidisciplinary technological projects. Prof. Gerardo Turcatti, directs the academic technological platform, Biomolecular Screening Facility (BSF) at the EPFL he created in 2006. In the framework of the NCCR-Chemical Biology, he is project leader of the program ACCESS (An Academic Chemical Screening Platform for Switzerland). Previously he co-founded and acted as CTO of Manteia S.A., a Swiss-based company that developed high throughput DNA sequencing technologies currently owned by Illumina and used in the ‘Next Generation Sequencing’ instruments. Prior to this experience, Prof. Turcatti had a long multidisciplinary career in R&D divisions of Biotechnology and Pharmaceutical companies with extensive expertise in several Chemical Biology-related disciplines such as Drug Screening, Chemical Biology, Bio-analytical Chemistry, DNA and Protein Chemistry. Prof. Turcatti earned his Master in Chemical Engineering at the University of Geneva and his PhD in Chemistry and Biochemistry from the EPFL where he received the award for the best doctoral thesis of the year.
Stewart ColeProfessor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.
